ZDHHC3 and neoplasm: PD‐L1 is specifically palmitoylated at Cys272 by ZDHHC3 in human colorectal cancer cell lines; inhibiting such palmitoylation promotes ubiquitin‐mediated protein degradation of PD‐L1, thereby activating antitumor immunity and significantly suppressing tumor growth [17].